Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,183 total articles
Hercules Capital director Robert P. Badavas acquired 5,000 shares on February 24, 2026, spending $75,050. The purchase comes while HTGC trades near its 52-week low and the company reports a modest increase in quarter-end net asset value per share. Piper Sandler lowered its rating and price target, and Hercules amended a loan agreement with Savara t…
Neal West, Executive Vice President and Chief Financial Officer of Kaiser Aluminum, sold 5,000 shares on February 23, 2026, in multiple trades that generated roughly $608,600. The stock has risen sharply over the last 12 months and is currently trading above InvestingPro’s Fair Value estimate. Kaiser reported better-than-expected fourth-quarter 202…
Arvinas Chief Accounting Officer David K. Loomis sold 1,108 shares on February 23, 2026, in an automatic transaction to cover tax obligations. The company has reported weak fourth-quarter 2025 financials while continuing clinical progress, and an analyst has adjusted the price target while keeping a Neutral stance.
Arvinas Chief Scientific Officer Angela M. Cacace had 3,609 shares sold automatically on February 23, 2026 to satisfy tax withholding connected to vested RSUs. The disposals were carried out at $12.16 per share, generating $43,885 in proceeds. The stock has since climbed to $13.30, posting a 76% six-month gain, while the company reported weaker-tha…
Alexander L. Cappello, a director at Cheesecake Factory Inc., sold 635 shares on February 23, 2026, totaling $40,474. The sale comes as CAKE stock has climbed more than 30% year-to-date. The company reported fiscal Q4 2025 results that modestly exceeded expectations but disclosed a drop in comparable restaurant sales. Analysts remain divided, citin…
Randy Teel, president and chief executive of Arvinas, Inc. (NASDAQ: ARVN), sold 4,786 shares of company stock on February 23, 2026, in two automatic transactions to satisfy tax withholding obligations tied to vested restricted stock units. The shares were sold at $12.16 each for roughly $58,197, a price below the company’s quoted $13.30 market pric…
Mitsui Sumitomo Insurance Co., Ltd. acquired $39,381,431 of common stock in W. R. Berkley Corporation (NYSE: WRB) across multiple transactions executed between February 23 and February 25, 2026. The purchases were made under a Rule 10b5-1 plan adopted October 3, 2025. W. R. Berkley reported fourth-quarter 2025 revenue above analyst expectations, EP…
EverCommerce Inc. CEO Eric Richard Remer sold 11,490 shares of common stock on February 25, 2026, for about $120,903 under a Rule 10b5-1 trading plan. Following the sale, Remer retains substantial direct and indirect stakes in the company. Separately, Raymond James and RBC Capital issued downgrades affecting Weave Communications and EverCommerce, r…
Kymera Therapeutics Chief Executive Officer executed a near $2.7 million stock sale and exercised options to acquire additional shares, while the company advances Phase 2b testing of KT-621 and secures an FDA Fast Track designation for atopic dermatitis. Analysts remain divided on catalysts and valuation.
Director Jennifer S. Grafton sold 1,600 shares of Farmland Partners Inc. (NYSE: FPI) on February 24, 2026, for $12.36 per share, totaling $19,776. The transaction, carried out under a Rule 10b5-1 plan adopted in November 2025, leaves Grafton with 10,400 shares. The sale coincides with FPI trading close to its 52-week high of $13 and a 34.6% year-to…
Yelp director Jedda Dan sold 1,464 shares on February 23, 2026, under a 10b5-1 plan, generating $30,773. The sale occurred while the stock traded near its 52-week low and follows a quarter in which Yelp beat modestly on EPS and revenue but provided cautious guidance and faced a lowered price target and a critical short report.
Christian Romaglino, a portfolio manager at BlackRock MuniHoldings Fund, INC. (NYSE:MHD), reported the sale of 684 shares on February 23, 2026, in a Form 4 filing with the Securities and Exchange Commission. The transaction, executed at $11.805 per share, totaled $8,074. The trade occurred as MHD was trading near its 52-week high; the fund currentl…
Arista Networks director Kelly Battles sold 422 shares of company stock on February 23, 2026, in transactions governed by a Rule 10b5-1 trading plan adopted June 10, 2025. The weighted sale prices ranged from $126.8497 to $131.464 for a total of $54,042. After the dispositions Battles retains 9,529 shares. The stock trades at $132.89, above the pri…
Innovex International (NASDAQ: INVX) Chief Executive Officer Adam Anderson sold 18,837 shares on February 24, 2026, for $28.50 per share, netting about $536,854. The transaction, carried out under a Rule 10b5-1 plan established March 14, 2025, leaves Anderson with 466,744 directly held shares. The stock trades near its 52-week high and has risen sh…
iRhythm Holdings' Chief Accounting Officer Marc Wade Rosenbaum sold 280 shares on February 24, 2026, in a transaction executed under a Rule 10b5-1 plan. The sale totaled roughly $39,454. The company reported a strong fourth quarter with revenue of $208.9 million, positive GAAP net income, and an adjusted EBITDA of $34.3 million, while analysts trim…
Mervin Smith, Executive Vice President of Strategic Business Operations at iRhythm Holdings, sold 732 shares of the company on February 24, 2026, generating proceeds of $103,146 under a Rule 10b5-1 trading plan. The transaction came amid a roughly 14.5% one-week decline in the stock, which was trading at $135.85 at the time of reporting. iRhythm al…
Ocular Therapeutix Chief Scientific Officer Jeffrey S. Heier sold 3,057 shares on February 23, 2026, for roughly $25,311 to satisfy tax obligations tied to vested restricted stock units. The transaction left Heier with 323,368 shares. The stock has since risen, and recent positive Phase 3 SOL-1 data for Axpaxli and divergent analyst reactions are i…
Peter Kaiser, Chief Development Officer at Ocular Therapeutix, sold 2,810 shares on February 23, 2026, for a total of $23,266 to satisfy tax withholding tied to vested restricted stock units. The transaction came as the stock climbed 38% over the prior week and follows mixed market responses to positive Phase 3 results for the company’s investigati…
Walton Family Holdings Trust, which owns roughly 10% of Walmart Inc., executed a series of sales between February 23 and February 25, 2026, disposing of common stock totaling $159.8 million. The transactions, recorded on a Form 4 filing, included four blocks sold at average prices from $125.6253 to $127.171. After the disposals, the trust continues…
Ocular Therapeutix CEO Pravin Dugel sold 20,056 shares on February 23, 2026 under an automatic instruction to cover tax withholding tied to restricted stock unit vesting. The transaction, disclosed in an SEC Form 4, was non-discretionary. The company recently reported positive Phase 3 results for AXPAXLI while analysts issued a range of price targe…
Meta Platforms Chief Operating Officer Javier Olivan sold 1,555 shares of Class A common stock on February 23, 2026, for about $1.01 million, according to an SEC Form 4. The transactions included both direct and indirect sales through family and LLC entities. The filing leaves Olivan with 17,039 directly held Class A shares. Market metrics cited in…
Reliance, Inc. (NASDAQ:RS) Executive Vice President and Chief Operating Officer Stephen Paul Koch executed sales totaling 24,060 shares on February 23, 2026, generating roughly $7.7 million across multiple trades. The share disposals were carried out in tranches at prices in the low $320s. On the same day Koch recorded an acquisition of 24,060 shar…
Steven S. Fendley, President of Kratos Defense & Security Solutions' U.S. Division, sold 7,000 shares of the company on February 23, 2026, under a 10b5-1 plan adopted May 12, 2025, raising roughly $647,976. The transaction occurred in two tranches and leaves Fendley with 334,648 Kratos shares. The insider sale coincides with recent analyst bullishn…
Mo Qatanani, Chief Scientific Officer at Scholar Rock Holding Corp (SRRK), sold 8,484 shares of common stock on February 23, 2026, for roughly $399,350 across three transactions. The sales occurred as the stock traded close to its 52-week peak, while the company navigates regulatory follow-up with the FDA for a manufacturing partner and receives va…
June C. Lemerand, Snap-on Inc's Vice President and Chief Information Officer, sold 1,378 shares on February 25, 2026, generating $534,075. The transaction occurred as the stock traded close to its 52-week high. Lemerand retains 2,912.7936 shares and holds a range of stock options, restricted stock units and performance units. Snap-on recently repor…
